China allows fully foreign-owned hospitals and foreign investment in gene technologies; China is assessing the compatibility of the international AI agreement with its own strategic plans; and China's Ministry of Finance strengthens its regulation of foreign accounting organizations, particularly for those that do not have offices in China
Chinese court rules against international hotel brand for misuse of cross-border personal data; EU and China establish mechanism to address difficulties in data transfers; and High-frequency futures traders question their survival in an increasingly hostile Chinese futures market
U.S. lawmakers call on the government to scrutinize drugmakers' clinical trials in China; China removes restrictions for foreign investments in the manufacturing and services industries; and Cross-Boundary Wealth Connect gains 10 new additional securities firms for increased offshore investment opportunities.
Revised Chinese Company Law requires mandatory worker representation in boardrooms; Shanghai's biomedical measures catch the most attention; and Merchants of Pinduoduo's international arm, Temu, struggle to sue the company due to its complex structure.
WeRide IPO shows another green light for overseas listing of Chinese companies; China imposes new regulations for local authorities to better implement its state secrets law overhaul; and two Chinese state departments release new rules for QFII to stimulate foreign securities investment.
U.S. lawmakers are worried about Microsoft's deal with a UAE-based AI company that has China ties; Nippon Steel ends joint venture with Baoshan; and China tightens regulation on hedge funds and programmed trading.